TWO parent viruses, A/Finland/4/74 (H3N2) and A/Okuda/57 (H2N2), virulent and attenuated respectively for man, showed similar differences of virulence in ferrets as judged by estimations of 5o °/o minimal infectious doses (MIDs0), the level and persistence of nasal infection, the height and duration of pyrexia and the level of lung infection. In ferrets, two recombinant clones, WRL 94 (H.~N2) and WRL lo5 (H~N2), were almost as virulent as A/Finland and indistinguishable from one another, a result which agreed well with genetic analysis (Hay et al. I977); the RNA pieces of these recombinants appeared identical and largely derived from the virulent parent (A/Finland).
INTRODUCTION
One method of obtaining strains of influenza virus of sufficient attenuation for live vaccines is the recombination of a current wild-type virulent strain with a known attenuated strain having different surface antigens (Beare, 1975) . Comparisons of virulence Of such recombinants in man (McCahon et al. 1976 ) are expensive, time consuming and possibly misleading unless they involve many volunteers. Methods are required for screening of strains for potential attenuation for man before the essential tests in humans are conducted on an adequate scale. Markers of attenuation that have been used are infection of organ cultures of human and ferret trachea (Mostow & Tyrrell, 1973; Hara et al. 1974) , RNA homology with the attenuated parent strain (Florent et al. I977) and infection of squirrel monkeys (Berendt & Hall, I977) , mice (McCahon & Schild, 1972) and ferrets (Toms et al. 1976; Davenport et al. I977; Fenton et al. 1977) . Of the animal models, the ferret shows the most promise because the disease syndrome is similar to that in man (Smith et al. I933; Sbope, 1934; Sugg & Nagaki, 1955) .
Previous studies on the pathogenesis of influenza in ferrets have demonstrated that two A/PR/8/34-A/England/939/69 (HaN2) recombinant clones (7a and 64d) exhibited virulence characteristics similar to those in man (7a, virulent; 64d, attenuated; Toms et al. I976,  oo22-1317/79/oooo-3425 $02.00 (~) I979 SGM 1977 a). Further, parallels have been demonstrated between the behaviour of A/New Jersey/ 8/76 (HswlN1) in ferrets and human volunteers (Toms et al. I977b ) . Four criteria were used to assess virulence in the ferret: minimal infectious dose, growth in the upper respiratory tract, lung involvement and pyrexia. In this study we extend these observations in ferrets to a further group of recombinants which have been clinically tested (McCahon et aL 1976) ; they were derived from A/Okuda/57 (H2Nz) and A/Finland/4/74 (H3N2), the attenuated and virulent parents respectively. Almost at the completion of the work, genetic analysis of the recombinants became available (Hay et al. 1977) . The relation of the results of ferret infection to those of human trials and to the genetic analysis was sufficiently interesting to underline the need for screening further recombinants. A simplified test in ferrets is described which might allow such screening to proceed rapidly.
METHODS
Strains of influenza virus. These were supplied by the Wellcome Research Laboratories, Beckenham, Kent. A/Okuda/57 (H2N 2) and A/Finland/4/74 (H~N~) were the attenuated and wild-type parent strains, respectively, from which recombinant clones WRL 94, WRL 95, WRL ioo and WRL ~o5 were derived (McCahon et aL ~976). Seed and working stocks were prepared as described previously (Sweet et aL 1974) except that working stocks were harvested after 24 h incubation only.
Infectivity assays and haemagglutination-inhibition (HI) tests. These were described by Toms et al. (I976) . Infectivities were expressed as 5 o % egg infectious doses (EIDso) or as 5o % egg-bit infectious doses (EBIDs0).
Intranasal inoculation of ferrets and collection of nasal washes. These were described by Toms et al. 0976, I977a) .
Lung collection andmaeeration. Taking care to prevent contamination, lungs were removed from freshly killed ferrets and stored at -7 ° °C. After thawing, the lungs were macerated in a Sorvall Omnimixer in lo ml of Hanks' balanced salts solution (Wellcome Reagents Ltd., Beckenham, Kent) containing 1% (w/v) bovine serum albumin, 0"044 % (v/v) sodium bicarbonate, IOO units/ml penicillin, ~oo/zg/ml streptomycin and 25 #g/ml tetracycline. The cups of the omnimixer were washed with Hanks' solution, the fluids pooled and centrifuged at r4oo g for IO rnin at 4 °C. The supernatants were titrated in Io to 12-day-old eggs.
Rectal temperatures. These were taken as described previously (Toms et al. 1976 (Toms et al. , 1977a . Groups of four ferrets were inoculated with progressive too-fold dilutions of virus suspensions. An animal was considered to have been infected if virus was shed in nasal washes up to 72 h p.i. and it had HI antibody to the homologous virus 14 days p.i.
RESULTS

Minimal infectious doses
A/Finland had a high infectivity for ferrets as did the two recombinant clones whose approximate MIDso were only about tenfold higher than that for A/Finland (Table I) . A/Okuda, on the other hand, had a lower infectivity (iooo-fold or more) than the other three viruses. maintained until the 5th or 6th day. A/Okuda produced a completely different result. Despite the high inoculum (IO 8"~ EIDs0 ~ ios MIDso/ferret), there was little replication and peak titres in the washes reached only 2& EBIDs0/ml at 12 h p.i. which was maintained until 3o h p.i. (Fig. I a) . Similar results were obtained with lower inocula (Io ~'7 and IO 4'7 EIDso ). The recombinant clones WRL 94 and WRL Io5 produced patterns (not shown) similar to that of A/Finland with a tendency to produce earlier first peaks, though at the same level as A/Finland, and higher residual levels (about io 4 EBIDso/ml) of virus from 2 to 5 days p.i.
Total virus titres (EIDer) of lung macerates from ferrets inoculated intranasally with lo 5 MIDs0 of A/Finland and A/Okuda are shown in Fig. r (b) . A/Finland produced mean titres > Io 5 EID~o by 2 days and peak titres of about ~o ~'~ EIDso at 3 to 5 days. In contrast A/Okuda could not be detected in lung macerates at any time. Like A/Finland the two recombinants replicated well in lung tissue and produced patterns almost identical with that shown for A/Finland in Fig. I (b) .
Pyrexia resulting from infection with the parent strains (A/Finland/4/74, A/Okuda/57) and recombinant clones WRL 94 and WRL Io5
The rectal temperatures of ferrets were measured at intervals after intranasal inoculation of Io 5 MIDs0 of all four viruses (Fig. 2) . A/Finland and the two recombinants produced major peaks of fever 36 to 6o h p.i. while A/Okuda produced no significant temperature rise. Small secondary peaks of fever occurred at xo8 h p.i. for A/Finland and WRL 94-The onset of the first major bout of fever (Fig. z) corresponded with the peak of nasal infection (Fig. I a) and the peak of fever with the rapid reduction of nasal infection (Fig. I a and  Fig. 2) , as noted for other viruses (Toms et al. 1977a) . The secondary bout of fever (Fig. 2) corresponded with the height of lung infection (Fig. I b) as noted for the A/New Jersey/ 8/76 strain (Toms et al. I977b) .
• In producing fever the recombinant clones resembled A/Finland and not A/Okuda. The results were analysed by two methods to see whether there were differences between the recombinant clones and A/Finland. In observations on 64 ferrets, twice the standard deviation of the pre-infection mean temperature averaged out at o. 7 °C and thus a rise of o'7 °C or greater was considered to be a febrile response. In the first method, the areas beneath the curves of the main bout of fever (36 to 60 h p.i.) which were >/0"7 °C, were compared for individual animals. The mean areas beneath the curves (calculated from individual animals; eight for each virus) were 37, 22 and al arbitrary units respectively for A/Finland, WRL 94 and WRL Io5. An analysis of variance of these areas showed that the fever caused by A/Finland was significantly greater than that caused by WRL 94 (P < o.ot) and WRL ~o5 (P < o-oz5) but the fevers caused by the recombinants were not significantly different (P > o'o5). In the second method, the sign test (Campbell, I974) was applied to the whole mean curves plotted in Fig. 2 ; the fever due to A/Finland was significantly greater than that due to WRL 94 (P < o'o4) and WRL 1o5 (P < o.ol), but there was no significant difference (P > o.o5) between the two recombinants. 94 and WRL Io5 using low inocula Fenton et al. (I977) reported that the timing of the peak of virus titres in nasal washes and of pyrexia after inoculation of low doses of virus could demonstrate differences of virulence between recombinants. Hence, groups of four ferrets were inoculated intranasally with lo MIDs0 of A/Finland, WRL 94, WRL lO5 and A/Okuda and virus titres in the nasal washes and rectal temperatures were monitored. The results were variable and unsuitable for analysis because: 0) the synchrony of nasal virus and fever rises found using high doses of virus were not obtained at low doses; and (2) a low dose of virus did not guarantee infection of all inoculated animals. In some cases animals only showed the first signs of nasal virus or rectal pyrexia 6o h or so after inoculation, hence they may have been infected by cross infection rather than by inoculation.
Attempts to detect significant differences between A/Finland/4/74 and recombinant clones WRL
A rapid screening test in ferrets for comparing the virulence ofrecombhTant viruses
When the results described above were viewed in relation to recent genetic analysis and to the reported behaviour of the strains in human volunteers, it was evident that a rapid screening test in ferrets of further recombinants with different and known genetic constitution might provide results of theoretical and practical importance (see Discussion). Using the four criteria: MIDs0, the initial level and degree of persistence of nasal infection, the height and duration of pyrexia and the level of lung infection, the following screening test was devised, bearing in mind the timing of the occurrence of the various parameters and what could be accomplished practically in screening many strains. The test could be accomplished in 2 weeks; the first for the infection and the second for virus titrations. Groups of four ferrets were inoculated intranasally with either 1o 2.7 or 4.7 EID5 ° of virus to assess whether the MID~o was high or low. Virus titres in the nasal washes were then' determined at 24, 3o, 48, 54 and 72 h p.i. and rectal temperatures taken at 3o, 48, 54 and 72 h. Preinfection temperatures were recorded on the day prior to infection only, once in the morning and again in the afternoon. Finally, for two ferrets receiving the high dose only, infectious virus was measured in lung macerates collected on the 4th day after inoculation.
The virulence of two further recombinant viruses, WRL 95 and WRL I oo, were examined in this rapid test. At 24, 30, 48, 54 and 72 h p.i. with the high dose the nasal wash titres of animals receiving WRL 95 and WRL 700 was 4"4 (s.c. o'3), 5"6 (o.I), 4"8 (o.2), 3"5 (o.2) and 2"5 (o'I) loglo EBID~o; and 5"o (o.2). 5"7 (o'3), 4"3 (o'4), 3"3 (o'3) and 2.8 (0"4) loglo EBID~o respectively. Corresponding rectal temperatures at 3o, 48, 54 and 72 h p.i. were 38"6 (o'2), 4t'o (o'l), 40"2 (0"3) and 39.2 (0"3) °C; and 39"0 (o'3), 40"5 (o.1), 40"2 (0.2) and 39"1 (o.I) °C respectively. Similar figures were recorded for animals receiving the low dose with some delay in the start of nasal infection. Thus, in nasal infection and fever production the recombinants proved similar to that of A/Finland and far removed from that of A/Okuda (Table I and Fig. I, 2) . The lung titres (108"1 for the high dose of clone WRL 95; IoS'~ for clone WRL IOO) were also similar to those for A/Finland.
DISCUSSION
In ferrets the two recombinant clones WRL 94 and WRL IO5 were similar to that of the virulent parent, A/Finland, and considerably different from the attenuated parent, A/Okuda. Statistical analysis of the extent and duration of pyrexia indicated that the recombinant clones were slightly less virulent than A/Finland but they themselves were indistinguishable by all the criteria used including pyrexia. In our hands, the methods suggested by Fenton et aL (1977) for distinguishing between recornbinants of similar virulence, namely assessment of nasal infection and pyrexia after a low inoculurn of virus, was unsuccessful. The method was not sufficiently consistent in either establishment of infection or producing synchrony of the parameters measured between similarly treated animals.
Genetical analysis of the recombinant clones (Hay et al. I977; Table 2 ) agreed well with the results of the virulence tests in ferrets. WRL 94 and WRL IO5 had identical genetical analyses and no differences in virulence were observed between these two in ferrets. On the other hand, clinical trials of WRL 94 and WRL 105 were anomalous with genetical analysis. WRL 94 was classified as 'over attenuated' after trials in a few volunteers, whilst WRL to5 was described initially as 'attenuated ' (McCahon et al. 1976 ) and when tested in larger numbers of volunteers produced some clinical reactions occasionally moderately severe (Moffatt et al. 1976; Stealey et al. 1976; Fell et al. 1977) . In our opinion, the results of extended trials in man on WRL Io5, which were not devoid of clinical reactions, are not inconsistent with its significant virulence for ferrets. These animals may be more responsive to influenza virus infection than adult humans with previous experience of influenza, even if the latter are devoid of antibody to the specific haemagglutinin, although they may be similar in response to young humans having no previous contact with influenza. It is pertinent that in recent human trials, ts recombinants, which were attenuated in volunteers lacking HI antibodies but containing anti-neurarninidase antibodies, produced febrile illness in doubly sero-negative subjects (Murphy et al. 1976 (Murphy et al. , 1978 .
The identical genetic composition and ferret virulence of clones WRL 94 and WRL 1o5 and the results of extended human trials on the latter, raises the possibility that the human trials on clone WRL 94 conducted in 22 volunteers, of whom only 7 were sero-negative to The relation between genetic analysis and virulence is likely to be complex because of the multi-factorial nature of virulence. To gain more information on this, the virulence of many recombinants with different genomes must be assessed. Such a procedure could reveal a particular combination of RNA pieces which might determine attenuation in a defined recombinant system and thus lead to candidate vaccine strains. The system described here and elsewhere (Toms et al. 1976, I977 a) was too complicated to screen many recombinants rapidly, hence it has been modified so that the essential parameters for any one strain can be obtained in a fortnight. This rapid screening test should indicate big differences in virulence between strains. Only two additional recombinants were available for preliminary trials of the rapid test. Clone WRL ~oo had the same genetic analysis as WRL 94 and Io5 (five gene pieces from A/Finland) ex, cept the RNA segment I was derived from A/Finland and not A/Okuda (Table 2 ). Clone WRL 95 had a further RNA segment (segment 7) derived from A/Finland and only differed from the latter in having segment 5 from A/Okuda (Table 2) . WRL ioo was judged virulent for man in tests with 22 volunteers of which ten were seronegative to the haemagglutinin (McCahon et al I976 ) and in the rapid screening test in ferrets it was virulent, clearly different from A/Okuda and indistinguishable from the virulent parent A/Finland. WRL 95 was judged less virulent than WRL loo and similar to WRL I o 5 in a test with five volunteers of which four were sero-negative to the haemagglutinin, which again indicates that caution is needed in interpreting trials with small numbers of volunteers; in the rapid screening test in ferrets WRL 95 was virulent and indistinguishable from A/Finland. No attempt was made to see if WRL l oo and 95 could be distinguished from each other or from A/Finland by the full test in ferrets, since the obvious need for identifying attenuated strains was to make and test additional recombinants with a more varied genome including some with less of their RNA pieces derived from A/Finland.
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